NCI Proposes Inviting Academic Labs To Submit New Therapies For Development
In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm
Research Funding: 30 Groups Sign Letter For Double NCI Budget
Tobacco Regulation: ACS Advocates Giving FDA Full Authority Over Tobacco
Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements
NIH On R29 Phase-Out; Grant Review Appeals Process Changed
Trending Stories
- As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida - mRNA vaccine for melanoma is hailed as a turning point in medicine
The data from Moderna and Merck’s trial have yet to be presented
